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Allergic rhinitis (AR) is a public health problem with high prevalence worldwide. We evaluated levels of speciﬁc IgE, IgA, and IgG4
antibodies to the Dermatophagoides pteronyssinus (Dpt) house dust mite and to its major allergens (Der p1 and Der p2) in serum
and saliva samples from allergic and nonallergic children. A total of 86 children were analyzed, from which 72 had AR and 14 were
nonallergic healthy children. Serum IgE and serum/salivary IgG4 levels to Dpt, Der p1, and Der p2 were higher in allergic children
whereas serum/salivary IgA levels to all allergens were higher in nonallergic children. IgE levels positively correlated with IgG4 and
IgA to all allergens in allergic children, while IgA levels negatively correlated with IgG4 to Dpt and Der p1 in nonallergic children.
In conclusion, mite-speciﬁc IgA antibodies predominate in the serum and saliva of nonallergic children whereas mite-speciﬁc
IgE and IgG4 are prevalent in allergic children. The presence of speciﬁc IgA appears to have a key role for the healthy immune
response to mucosal allergens. Also, speciﬁc IgA measurements in serum and/or saliva may be useful for monitoring activation of
tolerance-inducing mechanisms during allergen speciﬁc immunotherapeutic procedures, especially sublingual immunotherapy.
1.Introduction
Allergic rhinitis (AR) is a global public health problem and
it is gaining importance due to the rapid increase in its
prevalence worldwide [1]. In Brazil, in a study using the
International Study of Asthma and Allergies in Childhood
(ISAAC), Sol´ e et al. [2] found an average prevalence of
rhinitis from 25.7% in groups of children aged 6-7 years and
31.7% between adolescents aged 13-14. According to ARIA
(allergic rhinitis and its impact on asthma), AR is clinically
deﬁned as an inﬂammation of the nasal mucosa, mediated
by IgE after exposure to allergens, and the symptoms occur
most frequently for two or more days for more than 1 hour
[1, 3]. Recently, other allergen-speciﬁc antibodies such as
IgG, IgG4, and IgA have been reported to be involved during
the course of allergic diseases [4].
House dust mites (HDMs), especially Dermatophagoides
pteronyssinus, are considered an important source for aller-
gen sensitization and they are a major risk factor for allergic
respiratory diseases in genetically predisposed patients [5].
Their allergens are divided into groups according to their
biochemical composition, homology, and molecular weight.
Nowadays,20allergenshavebeendescribedforD.pteronyssi-
nus [6]. The group 1 (Der p1, 25kDa) allergens are located
in high concentration in faecal pellets [7], while those of the
group 2 (Der p2, 14kDa) are most found in components of2 Clinical and Developmental Immunology
the mite body [5]. Der p1 and Der p2 are considered major
allergensofD.pteronyssinusduetobeingrecognizedbymore
than 80% of mite-sensitive patients [8].
Allergens derived from D. pteronyssinus are potential
immunogens that are recognized by IgE, IgA, and IgG
subclasses in allergic individuals [4]. In most allergic chil-
dren, the levels of serum IgA are reduced and do not
increase with age, as occurs in nonallergic infants. Nonatopic
individuals respond with normal production of IgA against
exposure to environmental allergens, which would trigger
the mechanism of immune exclusion, preventing binding of
allergens to IgE-producing cells. In this context, in children
with IgA deﬁciency, this mechanism of immune exclusion
would not occur, allowing the contact of antigen with IgE-
producing plasma cells and thus triggering the mechanisms
of type I hypersensitivity [9, 10]. While the elevation of
serum IgE levels in response to environmental allergens is a
distinctive feature of atopy, allergen-speciﬁc IgG antibodies
to these allergens are detected in serum and saliva in
both atopic and nonatopic individuals [11]. IgG1 and IgG4
are the main subclasses of allergen-speciﬁc IgG and the
predominance of a certain class depends on the degree of
exposure to allergen [11].
The present study aimed to evaluate the levels of IgE,
IgA, and IgG4 antibodies speciﬁc to D. pteronyssinus and to
its major allergens, Der p1 and Der p2, in samples of blood
serum and saliva from allergic and nonallergic children.
2. Methods
2.1. Subjects. A total of 72 children aged 5 to 15 years, male
and female, with perennial allergic rhinitis with or without
intermittent or persistent, mild-to-moderate asthma were
recruited from the Program of Asthma and Rhinitis Control
of the Public Health System of Itumbiara, Go, Brazil. The
diagnosis of allergic rhinitis was based on the international
guidelines [1, 3] and that of asthma followed the GINA
executive summary [12]. As inclusion criteria, children
should have (i) clinical history of respiratory symptoms
relatedtothehousedustexposure;(ii)positiveskinpricktest
(SPT) to D. pteronyssinus allergen extract; (iii) presence of
serumIgEtoD.pteronyssinusallergensdeterminedbyELISA.
The exclusion criteria were children with previous speciﬁc
allergen immunotherapy, cardiovascular or malignant dis-
eases, the presence of upper airway infections in the last 30
days prior to the study, the use of antihistamines within the
previous week, and the use of oral or topic corticosteroids
within the previous 2 to 3 weeks. Therefore, allergic children
that enrolled in the study were under no inﬂuence of
these treatment conditions. As control group, 14 nonallergic
healthy children, with no symptoms or clinical history of
allergic diseases and negative SPT to a panel of standardized
aeroallergens, were selected among age- and socioeconomic
status-matched children attended in the Pediatric Service of
the Clinic Hospital of the Federal University of Uberlˆ andia,
Brazil. The study was approved by the Ethics Committee on
Human Research at the Federal University of Uberlandia and
informed consent was obtained from the children’s parents.
2.2. Mite Allergen Extract. D. pteronyssinus (Dpt) crude
extract was obtained from mite bodies and feces as described
elsewhere [13]. Brieﬂy, mite powder was triturated in liquid
nitrogen and allergens were extracted in 5mM borate-
buﬀeredsalinecontainingproteaseinhibitors.Aftercentrifu-
gation (20,000 ×gf o r4 5m i na t4 ◦C), the supernatant was
dialyzed, ﬁltered through a 0.22μmm e m b r a n ea n dp r o t e i n
concentration was determined [14]. For SPT, Dpt crude
extract was adjusted to a protein concentration of 2mg/mL
in phosphate-buﬀered saline (PBS, pH 7.0) containing 0.4%
phenol plus 50% glycerol and stored at 4◦C until use.
2.3.SkinPrickTest. AllchildrenunderwentSPTaccordingto
European Academy of Allergology and Clinical Immunology
guidelines [15], with a panel of aeroallergens, as follows:
mite (D. pteronyssinus, D. farinae, and B. tropicalis)e x t r a c t s
prepared as previously described [13] and standardized
commercial extracts of cockroaches (Blattella germanica
and Periplaneta americana), mold (Alternaria alternata)a n d
pet danders (Felis domesticus and Canis familiaris)( F D A
Allergenic Ltda, Rio de Janeiro, RJ, Brazil). A histamine
solution at 10mg/mL and the glycerol-buﬀered diluent of
the allergen preparation were used as positive and negative
controls, respectively, (IPI/ASAC, S˜ ao Paulo, Brazil). Skin
reactions were read after 15min and a wheal mean diameter
3mm larger than the negative control was considered a
positive SPT result.
2.4. Serum and Saliva Samples. Venous blood and saliva
samples were obtained from all children in parallel to SPT.
Serum samples were collected after centrifugation (700 ×g
for 10min) of blood samples (5mL) and were then stored
in aliquots at −20◦C until serological assays. Unstimulated
saliva samples (1–1.5mL) were collected from the oral cavity
of the children using standard Salivette (Sarstedt AG &
Co., Numbrecht, Germany) devices during approximately
3minasdescribedelsewhere[16].Sampleswereimmediately
placed on ice and centrifuged (3.000 ×g for 10min a 4◦C).
Supernatants were collected and stored in aliquots at −20◦C
until assays.
2.5. Serum and Salivary IgE, IgA, and IgG4 Levels to D.
pteronyssinus Allergens. Serum and salivary IgE, IgA, and Ig4
levels to D. pteronyssinus allergens were determined by using
conventional ELISA (for Dpt allergen) or reverse ELISA (for
Der p1 and Der p2 allergens) as previously described [17].
For Dpt allergen, high-binding microtiter plates were
coated overnight at 4◦C with Dpt crude extract (20μg/mL)
and then blocked with bovine serum albumin (BSA) at 1%
(for IgE and IgA) or 0.1% (for IgG4) in PBS plus 0.05%
Tween-20. Serum samples were diluted 1:2 (IgE), 1:50
(IgA), or 1:10 (IgG4) in the respective blocking buﬀers
and incubated for 2h at 37◦C. Likewise, saliva samples
w e r ed i l u t e d1 : 2( I g E ) ,1 : 2 0( I g A ) ,o r1 : 1 0( I g G 4 )i n
the respective blocking buﬀers and incubated for 2h at
37◦C. Subsequently, plates were incubated with biotinylated
secondaryantihumanIgE(1:1,000;Kirkegaard&PerryLab-
oratories, Gaithersburg, Md, USA), antihuman IgA (1:5,000Clinical and Developmental Immunology 3
for serum and 1:8,000 for saliva samples; Sigma Chemical
Co., St. Louis, Mo, USA) or antihuman IgG4 (1:5,000
for serum and 1:3,000 for saliva samples; Sigma Chemical
Co.) antibodies for 1h at 37◦C, followed by streptavidin-
peroxidase (1:500; Sigma Chemical Co.) for 30min at 37◦C.
The assay was developed by adding 0.01M 2,2 -azinobis
(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and 0.03%
H2O2. Optical density (OD) was determined at 405nm and
antibody levels were expressed in ELISA index (EI) for IgE
and IgG4 antibodies, as described earlier [18], according to
the following formula: EI = OD of the test sample/cut oﬀ,
where the cut oﬀ was established as the mean OD values
of negative control serum or saliva samples plus 3 standard
deviations. EI values >1.2 were considered positive for IgE
and IgG4 antibodies. For IgA detection, antibody levels
were expressed as arbitrary units per milliliter (AU/mL) and
calculated on the basis of a reference curve constructed with
a pool of serum or saliva samples with high levels of IgA
antibodies to Dpt and established as containing 1000AU/mL
at double dilutions ranging from 1000 to 0.977AU/mL by
using the Microplate Manager 4.0 (BioRad Laboratories Inc.,
Hercules, USA) software.
For Der p1 and Der p2 allergens, high-binding microtiter
plates were coated with mouse monoclonal antibody to
Der p1 (clone 5H8; Indoor Biotechnologies, Charlottesville,
Va, USA) or to Der p2 (clone 1D8; Indoor Biotech-
nologies, Charlottesville, Va, USA) at 1.0μg/well and then
incubated subsequently with Dpt extract, serum samples,
biotinylatedsecondaryantihumanIgE(1:1,000),antihuman
IgA (1:3,000) ou antihuman IgG4 (1:3,000), streptavidin-
peroxidase conjugate, and enzyme substrate as described
above for conventional ELISA. Levels of IgE and IgG4 to
majorallergens(Derp1andDerp2)wereexpressedasELISA
index (EI) as established for conventional ELISA. To obtain
thereferencecurveofIgAanti-Derp1andanti-Derp2,itwas
used in each ELISA plate a pool of serum or saliva samples
with high levels of speciﬁc IgA antibodies for each allergen
that were arbitrarily established as containing 1000AU/mL.
It is important to make clear that sera from nonallergic
subjects were randomly included in the same ELISA plate
along with sera from allergic patients. In addition, two
positive quality-control sera and three negative control sera
were included in each plate in order to calculate the cut-oﬀ
value of the reaction by ELISA index (EI) mite-speciﬁc IgE
and IgG4 antibodies.
2.6. Statistical Analysis. Statistical analysis was performed
using the GraphPad Prism 5.0 software (GraphPad Soft-
ware, Inc., San Diego, Calif, USA). As the antibody levels
were not normally distributed, comparisons were analyzed
using nonparametric tests. Diﬀerences between groups were
analyzed using the Mann-Whitney test. Diﬀerences in the
percentages of positive samples for IgG4 antibodies to mite
allergens between groups were analyzed by the Fisher exact
test. Correlation between antibody levels was analyzed by the
Spearman correlation test. Diﬀerences were considered to be
statistically signiﬁcant when P<0.05.
Table 1: Demographic and clinical characteristics of the study
subjects.
Characteristics
Groups
Allergic Nonallergic P value
Number of subjects 72 14 —
Age (yr) 10.0 ±3.11 0 .6 ±2.6N . S . a
Mean ± SD
Sex (M:F) 42:30 9:5 N.S.a
Clinical diagnosis (n,% )
Rhinitis 51 (71%) 0 <0.0001b
Rhinitis and asthma 21 (29%) 0 <0.0001b
Positive skin prick test (n,% ) §
Dermatophagoides
pteronyssinus 72 (100%) 0 <0.0001b
Dermatophagoides farinae 69 (96%) 0 <0.0001b
Blomia tropicalis 53 (74%) 0 <0.0001b
Blattella germanica 31 (43%) 0 0.0015b
Periplaneta americana 22 (31%) 0 0.0168b
Alternaria alternata 10 (14%) 0 N.S.b
Felis domesticus 27 (37%) 0 0.0039b
Canis familiaris 37 (52%) 0 0.0002b
§Skin prick test to aeroallergen extracts was considered positive for a mean
diameter of wheal size larger than 3mm than negative control (saline
diluent); N.S: nonsigniﬁcant.
aDetermined by the Student t-test.
bDetermined by the Fisher exact test.
3. Results
3.1. Subject Data. The demographic and clinical charac-
teristics of the study subjects are shown in Table 1.F r o m
a total of 86 children analyzed, 72 had allergic rhinitis
(M/F: 42/30; mean ± SD age: 10.0 ± 3.1yr) and 14 were
nonallergic healthy children (M/F: 9/5; mean ± SD age:
10.6 ± 2.6yr). There was no signiﬁcant diﬀerence regarding
the sex and age between the allergic and nonallergic children
(P>0.05). The frequency of allergic children with rhinitis
alone (71%) was higher than rhinitis associated with asthma
(29%) (P<0.0001). SPT results to aeroallergen extracts
revealed higher concomitant sensitization to the mites D.
pteronyssinus and D. farinae (96%) than to Blomia tropicalis
(74%) and to other aeroallergens (<55%) (P<0.0001), and
only the sensitization to Alternaria alternata (14%) was not
signiﬁcantly diﬀerent between the allergic and nonallergic
groups (P = 0.3559).
3.2. IgE Levels to Dpt, Der p1 and Der p2 Allergens. Levels of
serum IgE antibodies to Dpt extract were signiﬁcantly higher
in allergic (EI geometric mean [gm]: 5.97) than nonallergic
(EI gm: 0.79; P = 0.0004) children. Similar results were
observed for levels of IgE to Der p1 (EI gm: 6.59 versus 0.67;
P<0.0001) and Der p2 (EI gm: 9.00 versus 0.75; P<0.0001)
(Figure 1(a)). Nonetheless, levels of speciﬁc salivary IgE were
undetectable in both allergic and nonallergic children (data
not shown).4 Clinical and Developmental Immunology
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Figure 1 :( a )L e v e l so fI g Ea n t i b o d i e st oDermatophagoides pteronyssinus (Dpt) crude extract and its major allergens (Der p1 and Der p2) in
serum samples from allergic (n = 72) and nonallergic (n = 14) infants. Data are expressed in ELISA index (EI) and the geometric mean for
each allergen is indicated by horizontal bars. The dashed line indicates the cutoﬀ of the reaction (EI > 1.2). ∗∗∗P<0.0001 as determined
by the Mann-Whitney U test. (b), (c), and (d) Correlation between levels of serum IgE anti-Dpt versus anti-Der p1 (b), IgE anti-Dpt versus
anti-Der p2 (c), and IgE anti-Der p1 versus anti-Der p2 (d). The Spearman correlation coeﬃcient (r) and statistical signiﬁcance are also
indicated.
When analyzing correlation between IgE levels to Dpt
and its major allergens in allergic children, levels of IgE anti-
Dpt showed strong positive correlation with IgE anti-Der
p1 (r = 0.8418; P<0.0001) (Figure 1(b)) and IgE anti-
Der p2 (r = 0.8484; P<0.001) (Figure 1(c)). Similarly, IgE
levels anti-Der p1 positively correlated with IgE anti-Der p2
(r = 0.8112; P<0.0001) (Figure 1(d)).
3.3.IgALevelstoDpt,Derp1andDerp2Allergens. Represen-
tative reference curves of IgA antibodies to Dpt and its major
allergens, Der p1 and Der p2, in saliva samples are shown
in Figure 2.T h ec o r r e l a t i o nc o e ﬃcients were above 0.990 for
all the reference curves. The detection limits for these assays
were 7.8AU/mL for IgA anti-Dpt, and 3.9AU/mL for IgA
anti-Der p1 and IgA anti-Der p2 in both serum and saliva
samples. The inter- and intra-assay reproducibility of these
assays was evaluated by calculating the respective coeﬃcients
of variation that were below 15%.
Levels of serum IgA antibodies to Dpt, Der p1 and
Der p2, allergens were signiﬁcantly higher in nonallergic
(gm: 791AU/mL, 568AU/mL, and 407AU/mL, resp.) than
allergic (gm: 135AU/mL, 69AU/mL, and 103AU/mL, resp.;
P<0.0001) children (Figure 3(a)). Similar results were
observed for salivary IgA levels to Dpt, Der p1 and Der p2, in
nonallergic (gm: 858AU/mL, 889AU/mL, and 774AU/mL,
resp.) as compared to allergic (gm: 126AU/mL, 186AU/mL,
and 150AU/mL, resp.; P<0.0001) children (Figure 3(b)).
Correlation between IgA levels to Dpt and its major
allergens, Der p1 and Der p2, in serum or saliva samples
fromallergicandnonallergicchildren,areshowninFigure 4.
There was a strong positive correlation between levels of
serum IgA to Dpt and its major allergens as well as between
Der p1 and Der p2 allergens in both groups, particularly inClinical and Developmental Immunology 5
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Figure 2: Representative reference curves of IgA antibodies to Dermatophagoides pteronyssinus (Dpt) (a) and its major allergens Der p1 (b)
and Der p2 (c) in saliva samples. A pool of saliva samples with high levels of speciﬁc IgA antibodies for each allergen and established as
containing 1000 arbitrary units per milliliter (AU/mL) was used for each reference curve, using serial double dilutions ranging from 1000
to 0.977AU/mL. The curves were constructed with the GraphPad Prism 5.0 software by plotting the absorbance (OD) and concentration
(AU/mL) values, using the quadratic curve ﬁt. The correlation coeﬃcients (r) are indicated and the detection limits for these assays were
7.8AU/mL for IgA anti-Dpt, and 3.9AU/mL for IgA anti-Der p1 and IgA anti-Der p2.
nonallergic children (Figures 4(a), 4(b), and 4(c)). On the
other hand, salivary IgA levels to Dpt showed a moderate
positive correlation with IgA anti-Der p1 or anti-Der p2
in the allergic group, whereas these parameters were not
correlated in the nonallergic group (Figures 4(d) and 4(e)).
In contrast, levels of salivary IgA anti-Der p1 and anti-Der
p2 exhibited a strong positive correlation in both allergic and
nonallergic groups (Figure 4(f)).
No correlation was found between serum and salivary
IgA levels to Dpt, Der p1 and Der p2 allergens, in both
allergic and nonallergic children (Table 2).
3.4. IgG4 Levels to Dpt, Der p1 and Der p2 Allergens. Levels of
serum IgG4 antibodies to Dpt, Der p1 and Der p2 allergens,
were signiﬁcantly higher in allergic (EI gm: 3.47, 3.49, and
2.97, resp.) than nonallergic (EI gm: 1.62, 1.62, and 1.22,
resp.; P<0.05) children (Figure 5(a)). Similar results were
observedforsalivaryIgG4levelstoDptandDerp1inallergic
(EI gm: 2.15 and 1.93, resp.) as compared to nonallergic (EI
gm: 1.09 and 1.45, resp.; P<0.05) children (Figure 5(b)),
but levels of salivary IgG4 to Der p2 did not show signiﬁcant
diﬀerences between allergic and nonallergic children (P>
0.05) (Figure 5(b)). Percentage of positive serum samples
for IgG4 to Dpt and Der p1 were not signiﬁcantly diﬀerent
between allergic and nonallergic groups (P>0.05), but
allergic children showed higher positive rate of serum IgG4
to Der p2 than nonallergic ones (82% versus 50%; P =
0.016)(Figure 5(a)).Insalivasamples,itwasobservedhigher
p o s i t i v i t yf o rI g G 4t oD p ta n dD e rp 1i na l l e r g i c( 8 3 %a n d
82%, resp.) than nonallergic children (43% and 57%, resp.),
although signiﬁcant diﬀerences were found only for Dpt
(P = 0.002). Positivity of salivary IgG4 to Der p2 was not
signiﬁcantly diﬀerent between the allergic and nonallergic
groups (Figure 5(b)).6 Clinical and Developmental Immunology
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Figure 3: Levels of IgA antibodies to Dermatophagoides pteronyssi-
nus (Dpt) crude extract and its major allergens (Der p1 and Der
p2) in serum (a) and saliva (b) samples from allergic (n = 72) and
nonallergic (n = 14) infants. Data are expressed in arbitrary units
per milliliter (AU/mL) and the geometric mean for each allergen is
indicated by horizontal bars. ∗∗∗P<0.0001 as determined by the
Mann-Whitney U test.
Correlation between IgG4 levels to Dpt and its major
allergens, Der p1 and Der p2, in serum or saliva samples
from allergic and nonallergic children are shown in Figure 6.
There was a strong positive correlation between levels of
serum IgG4 to Dpt and Der p1 in both groups, particularly
in nonallergic children (Figure 6(a)), whereas a moderate
positive correlation was observed for serum IgG4 to Dpt
v e r s u sD e rp 2a sw e l la sb e t w e e nD e rp 1v e r s u sD e rp 2i n
the two groups (Figures 6(b), and 6(c)). On the other hand,
salivary IgG4 levels to Dpt, Der p1 and Der p2 were strongly
correlated among themselves in both allergic and nonallergic
groups (Figures 6(d), 6(e), and 6(f)).
When analyzing the correlation between serum and
salivary IgG4 levels to Dpt, Der p1 and Der p2 allergens,
it was found a weak, even though signiﬁcant positive
correlation for all allergens only in the group of allergic
children (P<0.05) (Table 2).
3.5. Comparison between Serum IgG4, IgA, and IgE levels to
Dpt, Der p1 and Der p2 Allergens. Serum levels of IgG4, IgA,
and IgE to Dpt, Der p1 and Der p2, were analyzed with
regards to correlation between IgG4 versus IgE, IgA versus
IgE, and IgA versus IgG4 levels to each allergen in allergic
and nonallergic groups (Table 3). Regarding the correlation
between speciﬁc IgG4 versus IgE levels, a signiﬁcant positive
correlation was found for antibodies to Dpt (r = 0.2351;
P<0.05) and Der p2 (r = 0.3585; P<0.001) only in
the allergic group. Similar correlation was observed between
speciﬁc IgA versus IgE to Dpt (r = 0.3533; P<0.001), Der
p1 (r = 0.3614; P<0.001), and Der p2 (r = 0.2327; P<
0.05) allergens. Concerning the correlation between speciﬁc
IgA versus IgG4 levels, a signiﬁcant positive correlation was
observed only to Dpt (r = 0.3122; P<0.001) in the allergic
group whereas a signiﬁcant negative correlation was seen for
Dpt (r =− 0.5824; P<0.05) and Der p1 (r =− 0.6799;
P<0.001) in the nonallergic group.
4. Discussion
Although children with allergic rhinitis sensitized to HDM
are known to have increased levels of allergen-speciﬁc serum
IgE,thepresenceofdiﬀerentantibodyisotypesinsaliva,such
as IgE, IgA, and IgG subclasses as well as the relationship
between serum and salivary antibodies or among antibody
isotypes are not yet well established. In addition, with the
increasingadvanceinapproachesofsublingualimmunother-
apy for allergic rhinitis, the measurement of HDM-speciﬁc
IgE, IgA, or IgG4 antibodies in saliva samples might be a
potential tool for monitoring the immunological changes
during the treatment.
In the present study, children with allergic rhinitis had
high serum IgE levels to Dpt and its major allergens, Der p1
and Der p2, which were strongly correlated among them-
selves. In addition, it was observed a tendency of increased
IgE levels to Der p2, demonstrating that children were more
sensitized to Der p2 than Der p1. Accordingly, previous
studies showed that IgE levels against Der p2 were always
higher than those against Der p1 in patient sera, conﬁrming
that Der p2 is a more immunologically active molecule than
Der p1 in inducing IgE synthesis [19, 20]. On the other
hand, speciﬁc salivary IgE levels were undetectable in both
allergic and nonallergic children, conﬁrming previous report
that IgE antibodies were not found in saliva [21]. These
ﬁndings suggest that mite-speciﬁc IgE antibodies were not
produced locally at the oral mucosa nor passively transferred
from serum or nasal secretions, even though it is well known
that speciﬁc IgE is an important class of immunoglobulin
in the nasal mucosa and appears to be locally produced
[21,22].Alternatively,negativesalivaryIgEdatacouldbedue
to low recovery of speciﬁc IgE in saliva samples collected by
the Salivette technique if mite-speciﬁc IgE antibodies were
present in very low concentrations in saliva, although other
antibody isotypes such as salivary speciﬁc IgA and IgG4 wereClinical and Developmental Immunology 7
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Figure 4: Correlation between levels of IgA antibodies to Dermatophagoides pteronyssinus (Dpt) crude extract and its major allergens (Der
p1 and Der p2) in serum (a–c) and saliva (d–f) samples from 72 allergic (•) and 14 nonallergic (◦) children. Data are expressed in arbitrary
units per milliliter (AU/mL) and the dashed line indicates a perfect correlation. The Spearman correlation coeﬃcients (r) and statistical
signiﬁcance are also indicated for allergic (on the upper left corner) and nonallergic (on the lower right corner) children.
eﬃciently detected using the same procedure. Accordingly,
standard Salivette devices have been used for a long time for
collectionof saliva samples that can be stored forseveral days
in the own Salivette or dried onto ﬁlter paper with good IgA
antibody recovery [16]. However, further studies could be
conducted for the validation of total IgA or IgE recovery as
well as the day-to-day variation using the Salivette device for
saliva sample collection.8 Clinical and Developmental Immunology
Table 2: Correlation between serum and salivary levels of IgA and IgG4 to Dermatophagoides pteronyssinus(Dpt) crude extract and its major
allergens (Der p1 and Der p2) in allergic and nonallergic children.
Groups
Serum versus saliva
IgA IgG4 IgA IgG4 IgA IgG4
anti-Dpt anti-Dpt anti-Der p1 anti-Der p1 anti-Der p2 anti-Der p2
Allergic r = 0.1802 r = 0.3667 r =− 0.0519 r = 0.3551 r =− 0.0547 r = 0.2901
(n = 72) P>0.05 ∗P<0.001 P>0.05 ∗P<0.001 P>0.05 ∗P<0.05
Nonallergic r = 0.2640 r =− 0.0396 r = 0.3407 r = 0.1894 r = 0.5209 r = 0.2970
(n = 14) P>0.05 P>0.05 P>0.05 P>0.05 P>0.05 P>0.05
r = Spearman correlation coeﬃcient; ∗statistical signiﬁcance was set for P<0.05.
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Figure 5:LevelsofIgG4antibodiestoDermatophagoidespteronyssi-
nus (Dpt) crude extract and its major allergens (Der p1 and Der
p2) in serum (a) and saliva (b) samples from allergic (n = 72) and
nonallergic(n = 14)infants.DataareexpressedinELISAindex(EI)
and the geometric mean for each allergen is indicated by horizontal
bars. The dashed line indicates the cut oﬀ of the reaction (EI > 1.2)
and percentages of positive IgG4 samples for each allergen are also
indicated. ∗P<0.05; ∗∗P<0.001; ∗∗∗P<0.0001 as determined by
the Mann-Whitney U test; #Statistical signiﬁcance determined by
the Fisher exact test (P<0.05).
In the current study, IgA levels to Dpt and its major
allergens, Der p1 and Der p2, were higher in both serum
and saliva samples from nonallergic than allergic children,
suggesting a protective role of allergen-speciﬁc IgA antibod-
ies for the development of respiratory allergic diseases. It has
been proposed that low levels of salivary IgA are associated
with the development of allergy [9]. Decreased total IgA
has already been described in the saliva of children with
atopy [23]a sw e l la sd e f e c t i v es a l i v a r yI g Ar e s p o n s e sa g a i n s t
the respiratory syncytial virus were found in symptomatic
allergic infants [24]. In another previous study, nonatopic
healthy individuals had increased Der p1-speciﬁc IgA pro-
duction in serum, but not for speciﬁc IgE antibodies [4].
The increase in speciﬁc IgA in the serum coincided with
increasedTGF-β,accountingfortheroleofIgAandTGF-βin
peripheralmucosalimmuneresponsestoallergensinhealthy
individuals [25]. In addition, the presence of speciﬁc serum
and salivary IgA in patients with allergic rhinitis appears
to have a concurrent immunoregulatory mechanism by
activating TGF-producing T regulatory cells in the attempt
to normalize the allergic reactions [25].
Contrasting to our ﬁndings, Kitani et al. [26]d e m o n -
strated that mite-speciﬁc IgA antibodies in serum and
sputum samples were signiﬁcantly higher in mite-sensitive
patients than in normal controls and mite-insensitive asth-
matic patients. Also, infants who developed allergy up to 2
years of age tended to have higher levels of total IgA and
cat allergen-speciﬁc IgA in saliva than nonallergic children
[9]. Another early study was also unable to detect IgA or
IgE antibodies to D. pteronyssinus in sera from nonallergic
persons, even though using a partially puriﬁed fraction of
mite extract in antigen-binding assays [27]. A more recent
study comparing Der p1-speciﬁc antibody levels in children
with allergic airway disease and healthy controls showed that
speciﬁc IgA levels in allergic children were not signiﬁcantly
diﬀerent from controls, but when the IgA/IgE ratio was
investigated,itwasfoundtobesigniﬁcantlylowerinchildren
with asthma, but not in children with allergic rhinitis as
compared to controls [4].
AnalyzingthecorrelationbetweenlevelsofspeciﬁcIgAto
Dpt and its major allergens, there was a strong correlation of
serum IgA levels among the three allergens, in both allergic
and nonallergic groups. In contrast, salivary IgA levels to
Dpt showed a moderate correlation with Der p1 and Der
p2 only in allergic children. In addition, no correlationClinical and Developmental Immunology 9
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Figure 6: Correlation between levels of IgG4 antibodies to Dermatophagoides pteronyssinus (Dpt) crude extract and its major allergens (Der
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was found between serum and salivary levels of IgA to the
three allergens in both groups. These ﬁndings suggest that
systemic immune responses are much more stimulated than
secretory immune responses in both allergic and nonallergic
children, and that IgA seems to be locally produced rather
than passively transferred from the serum. Accordingly, it is
long-time known that the great bulk of IgA antibodies in
secretions is locally produced [21, 28], although primed IgA-
producing B cells can migrate to distant mucosal surfaces
and, as result, the site of production of IgA antibodies
may not indicate the site of response to antigen [28]. It is
interesting to reinforce that the presence of high levels of10 Clinical and Developmental Immunology
Table 3: Correlation between serum IgG4, IgA, and IgE levels to
Dermatophagoides pteronyssinus (Dpt) crude extract and its major
allergens (Der p1 e Der p2) in allergic and nonallergic children.
Correlation Groups
Allergic Nonallergic
IgG4 versus IgE for Dpt 0.2351∗ 0.3484
IgG4 versus IgE for Der p1 0.1921 0.2310
IgG4 versus IgE for Der p2 0.3585∗∗ 0.4956
IgA versus IgE for Dpt 0.3533∗∗ −0.3815
IgA versus IgE for Der p1 0.3614∗∗ 0.0285
IgA versus IgE for Der p2 0.2327∗ −0.0418
IgA versus IgG4 for Dpt 0.3122∗∗ −0.5824∗
IgA versus IgG4 for Der p1 0.1172 −0.6799∗∗
IgA versus IgG4 for Der p2 0.1858 0.0813
Data are expressed as coeﬃcient of correlation of Spearman (r)w i t h
statistical signiﬁcance (∗P<0.05; ∗∗P<0.001).
speciﬁcIgA,particularlyintheserumofnonallergicchildren,
may be responsible to prevent allergen sensitization. In
the allergic group, however, signiﬁcant correlations between
levels of IgA versus IgE to the three allergens were observed,
supportingthatspeciﬁcIgAcanbeinducedforinhibitingthe
binding of allergens in IgE-producing plasma cells as already
previously described [9]. It has been also reported that IgA
deﬁciency was associated with the development of atopy
within the ﬁrst year in the oﬀspring of reaginic patients,
reinforcing the importance of the IgA antibody synthesis for
preventing the development of atopic diseases [29].
In addition to IgA antibody, previous studies have
demonstrated a protective activity for IgG subclasses, partic-
ularly IgG4, which is produced as result of a long-time nat-
ural allergen exposure or a speciﬁc allergen immunotherapy
[13, 30]. In the present study, serum IgG4 levels to Dpt and
its major allergens were higher in allergic than nonallergic,
reinforcing that antigens that induce IgE antibodies are
also good inducers of IgG4 antibodies [31]. These ﬁndings
were also supported, in the present study, by the positive
correlation found between serum IgG4 versus IgE levels
to Dpt and mostly to Der p2 in allergic, but not in
nonallergic children. Our results agree with a number of
studies reporting good correlations between speciﬁc IgE and
IgG4 levels after natural exposure to allergens in patients
with allergic airway diseases [13, 32], although there is a
report in Japan that did not ﬁnd such correlation between
levels of IgG4 and IgE to Der p2 allergen [33]. Interestingly,
ourresultsshowednegativecorrelationsbetweenserumIgG4
versus IgA levels to Dpt and Der p1 only in nonallergic
children,reinforcingthatthepresenceofspeciﬁcIgAappears
to have a key role for the healthy immune response to
mucosal allergens.
Likewise, salivary IgG4 levels to Dpt and Der p1, but
not to Der p2, were higher in allergic than nonallergic
children, supporting our previous report that Der p1 is a
more immunogenic molecule than Der p2 in inducing IgG4
synthesis [20]. In addition, the moderate positive correlation
between serum and salivary IgG4 levels to all allergens
found in allergic children, conversely to that observed for
speciﬁc IgA correlation, reﬂects that IgG4 is likely passively
transferred rather than locally produced.
The association of IgG4 with protective activity is related
to its function as blocking antibody or marker of tolerance
induction. The mechanisms for blocking antibody are the
competition for allergen between IgG4 and cell-bound IgE
antibodies [31] and IgE-facilitated allergen presentation, in
which this IgE-facilitation is prevented in the presence of
IgG4 antibody because of competition between IgE and
IgG4 antibodies, resulting in a decreased sensitivity of T
cells and consequently in a suppression of the late-phase
reactions [34, 35]. As marker of tolerance induction, IgG4
antibody measurements may be particularly valuable in
follow-up studies, where a considerable increase in IgG4
levels can be a strong indicator of the activation of tolerance-
inducing mechanisms [31]. This protective activity may be a
signiﬁcant underlying mechanism for the eﬃcacy of speciﬁc-
allergen immunotherapy.
Taken together, we can conclude that mite-speciﬁc
IgA antibodies predominate in the serum and saliva of
nonallergic children whereas mite-speciﬁc IgE and IgG4
antibodies are prevalent in allergic children. Also, levels of
serum IgE to total Dpt extract and its major components are
positively correlated with serum speciﬁc IgG4 or IgA levels
in allergic children, but serum IgA and IgG4 levels to Dpt
and Der p1 are negatively correlated in nonallergic children.
Therefore, the presence of speciﬁc IgA appears to have a key
role for the healthy immune response to mucosal allergens.
Also, speciﬁc IgA measurements in serum and/or saliva may
be useful for monitoring activation of tolerance-inducing
mechanisms during allergen-speciﬁc immunotherapeutic
procedures, especially sublingual immunotherapy.
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